Cifbax B Eye/ear Drops contains Betamethasone. Cifbax B Eye/ear Drops uses:
Indicated in atopic, infantile & discoid eczema; prurigo nodularis; Psoriasis (excluding widespread plague psoriasis); lichen simplex or planus; contact sensitivity reactions; seborrhoeic dermatitis; discoid lupus erythematosus & adjunct to systemic steroid therapy in generalized erythroderma.
|Brand Name:||Cifbax B Eye/ear Drops|
|Manufacturer:||SCOTT EDIL PHARMACIA LTD|
|Last Updated:||2020-11-21 18:15:00|
Cifbax B Eye/ear Drops contains Betamethasone 0.01 %. Cifbax B Eye/ear Drops doses
Apply sparingly to the affected area 2 to 3 times daily until an improvement occurs.
Burning, itching, irritation, dryness, folliculitis, hypertrychosis acneiform eruptions, perioral dermatitis, allergic contact dermatitis, maceration of the skin, secondary infection, skin atrophy, striae and miliariamay be reported.
Cifbax B Eye/ear Drops valerate is a potent topical corticosteroid. Topical corticosteroids have anti-inflammatory, antipruritic and vasoconstrictive actions when administered topically.
Avoid long-term therapy particularly in infant & children; the treated area should not be bandaged or otherwise covered or wrapped as to be occlusive unless directed by the physician. Avoid contact with eyes.
Increased hyperglycaemia and hypokalaemia with thiazide diuretics. Increased incidence of peptic ulcer or GI bleeding with concurrent NSAIDs admin. Response to anticoagulants altered. Dose of antidiabetics and antihypertensives needs to be increased. Decreases serum concentration of salicylates and antimuscarinic agents.
Potentially Fatal: Reduced efficacy with concurrent use of carbamazepine, phenytoin, primidone, barbiturates and rifampicin. Enhanced effect in women taking oestrogens or oral contraceptives.
There are no adequate and well controlled studies in pregnant women on teratogenic effects from topically applied corticosteroids and should not be used extensively for a prolonged period. Caution should be excercised when topical corticosteroids are administered in nursing women.
Cifbax B Eye/ear Drops is contraindicated in patients with a history of hypersensitivity to any of the components of the preparation. Cifbax B Eye/ear Drops Eye/Ear/Nasal Drops is contraindicated in Herpes simplex virus infection of the eye; known sensitivity or allergy to any ingredient; red eye due to unknown causes; viral or fungal infections in the treatment area; tuberculosis, glaucoma etc.
Long-term intensive topical use may lead to systemic effects
Protect from light. Do not freeze. Store between 15 °C and 30 °C.
Cifbax B Eye/ear Drops Eye/Ear Drops price in India 0